A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attenti… (NCT07572240) | Clinical Trial Compass
RecruitingNot Applicable
A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals
India72 participantsStarted 2026-07-27
Plain-language summary
The goal of this clinical trial is to learn about the effects of AP-Brain collagen peptide on attention, focus, and memory in adults who are stressed but otherwise healthy.
The main questions it aims to answer are:
* How does AP-Brain affect a participant's attention, focus, stress, and memory?
* Is there a difference in the effects between a higher dose and a lower dose?
* What are the side effects, if any, for participants taking AP-Brain?
Researchers will compare two different doses of AP-Brain to see how they affect brain function and stress levels.
Participants in this study will be asked to:
* Take one of two the doses of AP-Brain once a day for 56 days.
* Visit the study center for regular checkups.
* Complete tasks that measure memory, focus, and attention.
* Answer survey questions about their stress levels.
* Provide blood samples and have vital signs checked.
* Have the brain's response to tasks monitored to see how it affects attention and alertness.
Who can participate
Age range
35 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Individuals ready to give voluntary, written informed consent to participate in the study.
* Male and female individuals of age between 35 to 70 years (both values included).
* Individuals with body mass index (BMI) between 18.5 kg/m\^2 to 29.9 kg/m\^2 (both values included).
* Perceived Stress Scale (PSS) scores between 14 to 26 (both values included).
* Individuals with mild cognitive impairment as indicated by Addenbrooke's Cognitive Examination (ACE) III scores between 75 to 88 (both values included).
* Self-reported mild difficulties in focus, attention, or memory.
* Progressive cognitive complaints like stress, disturbed sleep etc. reported by participant.
* Individuals willing to consume an investigational product from bovine source.
* Individuals willing to complete all study-related and clinical study visits as per protocol.
Exclusion Criteria:
* Clinically diagnosed with Attention Deficit Hyperactivity Disorder (ADHD).
* Clinically diagnosed with mental disorders (diagnostic and statistical manual of mental disorders: DSM-5-TR), namely but not limited to epilepsy, anxiety, depression or Alzheimer's disease.
* Individuals with a medical history of cardiac disease, respiratory disorders, kidney disorder, liver disorder, or seizure disorders or other chronic health conditions requiring medication.
* Individuals with uncontrolled hypertension (systolic blood pressure greater than or equal to 140 mmHg or diastolic blood pressure greater than or e…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change from Baseline and Different Doses on Selective Attention and Focus by Stroop Color-Word Test at Day 56